Accuray (FRA:XEJ) Institutional Ownership : 36.29% (As of May. 21, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Accuray Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Accuray's institutional ownership is 36.29%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Accuray's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Accuray's Float Percentage Of Total Shares Outstanding is 98.38%.

Accuray Institutional Ownership Historical Data

The historical data trend for Accuray's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accuray Institutional Ownership Chart

Accuray Historical Data

The historical data trend for Accuray can be seen below:

	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30
Institutional Ownership	39.67	39.39	39.14	36.16	36.29	36.50	36.34	36.18	36.45	36.29

Accuray Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Accuray (FRA:XEJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Accuray Inc (FRA:XEJ) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

ARAY:USA

Address

1240 Deming Way, Madison, WI, USA, 53717

Website

https://www.accuray.com

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

Accuray (FRA:XEJ) Headlines

No Headlines